Charava

Elysium Hope

Elysium Hope sells a tightly curated line of longevity-focused dietary supplements and at-home biomarker test kits, all positioned in the premium price tier (single formulas US $60–120, multi-month stacks >$300). Orders are placed only through the brand’s own e-commerce site, which ships worldwide from U.S. and EU fulfillment hubs; no retail or marketplace distribution is used. The company’s distinction is its link to the MIT lab that discovered nicotinamide riboside as a NAD+ precursor; Elysium licenses that IP and uses it as the anchor of its flagship “Basis” cellular-health capsule. Every batch is NSF-certified, and the brand funds peer-reviewed human studies that are published in Nature Partner Journals, a rarity in the supplement space. Customers are 35- to 65-year-old professionals who track sleep, VO2 max, and epigenetic age and are willing to pay for evidence-based interventions rather than generic multivitamins. The brand speaks to the quantified-self ethos: science first, longevity as an attainable goal, and transparency via public COAs and anonymized data summaries. Elysium Hope competes in the high-end “nutraceuticals-for-aging” segment against other biotech-backed pill and testing brands. It differentiates by coupling patented molecules with in-house clinical trials, presenting results in plain language, and offering an optional subscription that pairs supplements with repeat biomarker panels to demonstrate measurable change over time.

Age isn't destiny when you have data on your side

Nesteen

Nesteen.com is a direct-to-consumer skincare house that concentrates on facial serums, under-eye patches, LED therapy devices and refillable “tool + capsule” systems. Everything sits in the premium tier—single serums run $60-$90, devices $120-$220—but is kept online-only to hold retail margins down and keep formulas small-batch. The brand’s hook is data-driven personalization: a 90-second skin-diagnostic quiz feeds an algorithm that selects actives (encapsulated retinal, liposomal vitamin C, growth-factor peptides) and then pairs them with a low-level light or micro-current device calibrated to the user’s impedance readings. The best-known SKU is the Nesteen Renew Wand + 28-day Precision Capsule set, which sold out three production runs within two months of launch. Core buyers are 25-40-year-old urban professionals who track sleep, HRV and glucose on their phones and want the same quantified approach for their skin; they value clinical proof (every formula is tested at 2× concentration in double-blind trials) and carbon-neutral shipping. The brand voice is gender-neutral and tech-forward, appealing to consumers who would rather optimize than cover up. Nesteen competes in the intersection of medical-grade topicals and at-home beauty tech; against both, it differentiates by bundling software-guided hardware with sealed, single-dose actives that remove user error and oxidation risk, while publishing raw trial data in plain language instead of before-and-after photos.

Skin optimization that actually measures what it changes

Renaisa

Renaisa is a direct-to-consumer skincare label that concentrates on science-backed serums, barrier-support moisturizers and targeted treatment capsules; everything is sold exclusively through renaisa.com. Price points sit in the mid-range tier, with most 30 ml serums between $38-$58 and treatment sets capped at $120. The site ships worldwide from U.S. fulfillment centers and offers refill pouches that knock 15% off the original bottle price. The brand formulates without fragrance, essential oils or silicones and publishes third-party lab data for irritation testing and active potency on every product page. Its “ChronoRelease” encapsulation technology—visible as micro-beads that dissolve on contact—allows 12-hour staggered delivery of retinaldehyde and vitamin C in the flagship Night Shift serum, the line’s best-selling SKU. Renaisa also keeps production runs below 1,000 units to stamp each box with a batch code that links to a publicly accessible stability report. Customers are 25-40-year-old professionals who track ingredient research on Reddit skincare threads and want clinical-grade results without dermatologist-office mark-ups. They value transparency over influencer hype, often cross-checking INCI lists and pH metrics before purchasing, and appreciate the brand’s carbon-neutral shipping and optional aluminum cap refills that reduce plastic by 60%. Renaisa competes with mid-priced “clinical-clean” brands that straddle drugstore and prestige shelves, differentiating itself by publishing raw lab data, eliminating all sensitizing additives and limiting batch sizes to guarantee freshness. Where rivals rely on retail margins and frequent promo cycles, Renaisa’s online-only model funds smaller, evidence-driven launches and keeps unit costs lower than comparable dermatologist-distributed formulas.

Batch-tested science you can verify before it touches your skin

3rvie

3rvie is an online-only skin-care and wellness label that focuses on science-backed serums, moisturizers and ingestible beauty supplements. Most SKUs sit in the mid-range bracket, running USD 28-68 for 30-60 ml treatments and about USD 45 for a 30-day supply of capsules. Everything is sold direct-to-consumer through 3rvie.com with limited-edition drops restocked monthly. The line is built around a proprietary “3-R complex” (repair-resilience-radiance) that pairs adaptogenic botanicals with clinical actives such as 0.3% retistat™ and 5% niacinamide at pH-optimized levels. All formulas are EU- and US-compliant, cruelty-free, and filled in airless amber glass to preserve stability; the best-selling 3rvie Renewal Serum routinely sells out within hours of restock. Transparent batch-level COAs and QR-linked clinical data reinforce the “evidence over hype” positioning. Core buyers are 25-40-year-old urban professionals who track sleep, diet and skin metrics and want streamlined routines that fit a minimalist, gender-neutral aesthetic. They value measurable results, clean labeling and carbon-neutral shipping, and they are comfortable pre-ordering to secure new drops. 3rvie competes in the crowded dermaceutical-meets-clean-beauty space against brands that layer heavy marketing over similar active percentages. It differentiates by publishing peer-reviewed pilot-study results, keeping SKUs under ten to avoid confusion, and offering a 60-day empty-bottle refund policy that lowers trial risk without heavy discounting.

Science-backed serums that prove results, not promises

• Cruelty-free

Nice Vie

Nice Vie is a direct-to-consumer beauty and wellness label that focuses on ingestible skincare, powdered supplements, and minimalist topical treatments. All SKUs sit in the mid-range tier: single-item prices run $28-$65, while curated 30-day sets land just under $120. Sales are online-only through nicevie.com; the site ships worldwide from U.S. and EU fulfillment hubs and offers a subscribe-and-save option that trims 15 % off every order. The brand formulates around “skin from within,” pairing clinically dosed nutraceuticals with low-ingredient-count topicals. Best-known SKUs include the Marine-C Collagen Sachets and the 3-step “Glow System” kit, both packaged in recyclable, single-color pouches and frosted glass to cut plastic weight by 60 %. Every batch is third-party tested for heavy metals and posted in an on-site certificate library, a transparency step few mid-price ingestible lines match. Core buyers are 25-40-year-old urban professionals who track sleep, hydration, and microbiome data and prefer beauty budgets under $80 a month. They value science-backed claims, clean label lists, and carbon-neutral shipping over prestige branding; Instagram and Reddit skincare communities drive 70 % of referral traffic. Nice Vie competes in the crowded ingestible beauty space dominated by subscription collagen startups and department-store supplement spin-offs. It differentiates through moderate pricing, public COAs, plastic-light packaging, and a tightly edited SKU list—positioning itself as the “evidence-first” upgrade for customers who have outgrown flavored gummies but balk at $200+ luxury beauty nutrition.

Science-backed beauty that costs less and ships carbon-neutral

• Recycled

Telomas

Telomas sells science-based longevity supplements built around telomere and cellular-health research. The core line is oral capsules (Telomax, Telomax-R, Telomax-ER) priced USD 79–149 per 30-day supply, placing the brand in the premium tier. Orders are placed only through telomas.com; no retail or marketplace distribution is used. Formulations are anchored by TA-65® (cycloastragenol) and Astragaloside IV, compounds referenced in peer-reviewed telomerase-activation studies, and every lot is third-party tested for purity and heavy-metal content. The company positions itself as a clinician-trusted source of “pharmaceutical-grade telomere support,” and its 90-capsule Telomax-ER is frequently cited in biohacker forums for standardized 25 mg cycloastragenol content. Buyers are 35-65-year-old professionals who track biological-age metrics, follow quantified-self protocols, and are willing to pay for research-backed interventions. The brand appeals to consumers who value transparency (Certificates of Analysis posted online) and a medical-advisory board that includes anti-aging M.D.s. Telomas competes in the narrow niche of high-potency telomerase activators, a space dominated by small labs that often lack published testing. It differentiates through verified active-ingredient levels, batch-traceable chromatograms, and a 30-day money-back guarantee—risk-reduction features rarely matched by peer suppliers.

Pharmaceutical-grade telomere science, tested and traceable, for people who optimize their biology

DOXYVA

DOXYVA sells a single flagship line of trans-dermal micro-circulation devices that deliver ultra-purified medical-grade carbon dioxide through a patented fingertip or thumb chamber. The system is positioned in the premium price tier, with starter kits and monthly refill cartridges sold direct-to-consumer through the brand’s own website and select telehealth platforms; no retail stores carry the product. The brand’s core differentiator is its clinically validated ability to raise skin and blood perfusion levels in under five minutes, a claim supported by peer-reviewed studies and FDA Class I registration. DOXYVA markets itself as a non-invasive wellness technology that supports vascular health, athletic recovery, diabetic wound care, and skin rejuvenation in one portable device. Primary buyers are health-conscious adults 35-65 managing diabetes, hypertension, or chronic pain, together with athletes seeking faster recovery and biohackers tracking perfusion metrics. The customer base values data-driven, drug-free solutions and is willing to pay for medical-grade technology that can be used at home without prescription. DOXYVA competes in the crowded wearable recovery and circulatory-health space against compression boots, infrared sleeves, and low-level light therapy pads. It separates itself by offering a glove-sized, five-minute protocol that directly increases micro-vascular blood flow rather than merely masking symptoms, and by publishing third-party clinical data that link its CO2 delivery to measurable improvements in endothelial function and wound closure rates.

Five minutes to measurably better blood flow, clinically proven and portable

Enorsia

Enorsia sells performance-oriented nutritional supplements and nootropic capsules, grouped under “Energy,” “Focus,” “Recovery,” and “Sleep” lines. Single bottles run $35-55 and variety bundles $110-140, placing the brand in the upper-mid price tier. All commerce is handled through the company’s own site; no retail distribution is listed. The formulas are built around patented branded ingredients—e.g., enXtra® alpine galanga for alertness, SerinAid® phosphatidylserine for cognitive recovery—and every lot is posted with third-party COAs for purity and heavy-metal content. Enorsia positions itself as “clinical-grade supplementation without prescription,” and its best-known SKU is the two-capsule “Focus+Energy” stack that combines 150 mg caffeine with 300 mg alpha-GPC. Core buyers are 25-45-year-old professionals, e-sports competitors, and bio-hackers who track productivity metrics and want drug-free cognitive enhancement. They value open-source labeling, short ingredient lists, and the option to buy once or subscribe at a 15 % discount. Enorsia competes in the direct-to-consumer “clean nootropic” space against pill and powder brands that rely on proprietary blends or stimulant-heavy pre-workouts. It differentiates by publishing exact mg figures, avoiding artificial colors or fillers, and offering a 45-day “empty-bottle” refund policy even on opened product.

Clinical precision meets daily performance, no prescription required